About a year and a half after telegraphing plans to shift its headquarters from New Jersey to Philadelphia, CDMO Adare Pharma Solutions appears to be turning out the lights at another facility in the ...

According to Precedence Research, the global cell and gene therapy CDMO market size is expected to be worth over USD 74.03 billion by 2034, increasing from USD 8.07 billion in 2025. The market is ...

The Buckland Group launched Quvara Medical as the newest CDMO to debut this year after buying a former Becton Dickinson manufacturing site in the U.K. for an undisclosed price. Quvara joins the ranks ...